• MHC Class I by most cells in adult Including neural stem cells. |
• Embryonic cells have little or none but will express them on inflammation or differentiation |
• MHC Class II by professional APC such as T cells, B cells, macrophages, endothelial cells and thymic epithelial cells |
• Different HLA antigens responsible for rejection at different time points. HLA-DR mismatch important in the first 6 months, the HLA-B in the first 2 years, and HLA- A mismatches over the long-term |
• Foreign antigens are presented by cells expressing Class I or II peptides on surface and lead to activation of T cells, B cells and macrophages. |
• ABO blood groups and sex differences may have effects on transplants |
• T–regs, Complement, atypical MHC antigens (HLA G), minor antigens and modulators of local immune response (indoleamine, NO, etc.) can exacerbate or inhibit rejection |
• GVH (graft versus Host) immune issues may be important for blood derivatives |